Immuneering Recognizes Melanoma Awareness Month
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 3.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.68 | 52 Week High | $0.04 | |||
| Open | $3.68 | 52 Week Low | $0.00 | |||
| Day High | $3.68 | P/E | N/A | |||
| Day Low | $3.68 | EPS | $-0.09 | |||
| Volume | 269 | |||||
